Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2020, Vol. 34 ›› Issue (4): 53-55.doi: 10.6040/j.issn.1673-3770.1.2020.055

Previous Articles     Next Articles

Neovascular glaucoma in ocular ischemic syndrome: a case report and literature reviewQIN Shuqi1, WANG Luping1, JIANG Bin2, WANG Yanling1 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, China; 2. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, ChinaAbstract:

ObjectiveTo discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. MethodsThe medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. ResultsAfter three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. ConclusionOcular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.   

  1. Key words:Ocular ischemic syndrome;
    Neovascular glaucoma;
    Multidisciplinary diagnosis and treatment眼缺血综合征(ocular ischemic syndrome, OIS)是颈动脉狭窄或闭塞引起脑和眼供血不足, 从而产生一系列脑部和眼部症状的疾病[1]。OIS在临床上并不少见, 但是因其起病隐匿, 缺血程度不同, 使得眼部及全身表现复杂多样, 在临床上不易确诊, 常被眼科医生、神经科医生、心脏科医生、血管外科医生漏诊或误诊, 从而导致患者错过早期的治疗时机, 最终发展成不可逆的视力下降[2]。现将我科门诊接诊的一例右眼眼缺血综合征并发新生血管性青光眼患者的多学科诊疗过程与反思报告如下。
  • Received:2020-05-31 Online:2020-07-20 Published:2020-08-28

Abstract: Objective To discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. Methods The medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. Results After three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. Conclusion Ocular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.

Key words: Ocular ischemic syndrome, Neovascular glaucoma, Multidisciplinary diagnosis and treatment

CLC Number: 

  • R765.21
[1] 王艳玲. 眼缺血综合征的诊断与治疗[M]. 北京:人民军医出版社, 2012.
[2] Gologorsky D, Mohsenin A. Ocular Ischemic Syndrome. In: Medina C, Townsend J, Singh A. Manual of Retinal Diseases.
[3] Brown GC, Brown MM, Sharma S. The ocular ischemic syndrome[M] //Retinal and Choroidal Manifestations of Selected Systemic Diseases. New York, NY: Springer New York, 2012: 451-464.
[4] Jo YJ, Choi SK, Park SH, et al. Initial clinical manifestations of ocular ischemic syndrome in koreans[J]. J Korean Ophthalmol Soc, 2019, 60(12): 1231. doi:10.3341/jkos.2019.60.12.1231.
[5] 杨秀芬,李红阳,赵露,等. 眼缺血综合征的临床及影像学特点分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 119-123. doi: 10.6040/j.issn.1673-3770.0.2018.526. YANG Xiufen,LI Hongyang,ZHAO Lu,et al.Clinical and imaging characteristics in patients with ocular ischemic syndrome[J].Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 119-123. doi: 10.6040/j.issn.1673-3770.0.2018.526.
[6] Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55(1): 2-34. doi:10.1016/j.survophthal.2009.02.024.
[7] Mills RP. Anterior segment ischemia secondary to carotid occlusive disease[J]. J Clin Neuroophthalmol, 1989, 9(3): 200-204.[PubMed]
[8] 中华医学会眼科学分会青光眼学组. 中国新生血管性青光眼诊疗专家共识(2019年)[J]. 中华眼科杂志, 2019, 55(11):814-817. doi: 10.3760/cma.j.issn.0412-4081.2019.11.005.
[9] 王艳玲. 建立多学科综合诊疗模式,提高眼缺血综合征诊治水平[J]. 中华眼底病杂志, 2013, 29(3):233-236. doi: 10.3760/cma.j.issn.1005-1015.2013.03.001. WANG Yanling. Establishment of multidisciplinary diagnosis and treatment patterns for ocular ischemic syndrome[J].Chinese Journal of Ocular Fundus Diseases, 2013, 29(3):233-236. doi: 10.3760/cma.j.issn.1005-1015.2013.03.001.
[10] Lauria AL, Koelling EE, Houghtaling PM, et al. Carotid Endarterectomy for Ocular Ischemic Syndrome: A Case Report and Review of the Literature[J]. Ann Vasc Surg, 2020. doi: 10.1016/j.avsg.2020.03.005.
[11] 狄宇, 叶俊杰. 眼缺血综合征二例[J]. 中华眼科杂志, 2019, 55(6):454-457. doi: 10.3760/cma.j.issn.0412-4081.2019.06.009.
[12] 张子靖, 马翔. 颈动脉系统影像学检查在眼缺血综合征中的临床应用[J]. 眼科学报, 2018(2):113-117.doi:10.3978/j.issn.1000-4432.2018.05.02 ZHANG Zijing,MA Xiang.Clinical application of carotid artery system imaging examination in ocular ischemic syndrome[J].Eye Science,2018(2):113-117.doi:10.3978/j.issn.1000-4432.2018.05.02
[1] Ocular ischemic syndrome(OIS)is a severe ophthalmic disease caused by ocular hypoperfusion, which occurs due to stenosis or occlusion of the common or internal carotid arteries. The clinical presentations and signs of OIS are complex, incidental, and different. OIS is easily misdiagnosed or remains undiagnosed because of its asymptomatic onset and complicated ocular manifestations. Therefore, it is crucial to trace the etiology of OIS. Presently, different imaging modalities can evaluate the carotid artery blood supply, collateral circulation, and brain perfusion. Thus, appropriate modalities must be selected for OIS diagnosis based on their advantages and disadvantages. Furthermore, the auxiliary examination results should be accurately and promptly considered and interpreted when establishing a diagnosis of OIS. Thus, the management of OIS requires cooperation with ophthalmologists, cardiologists, and neurologists.. Correct interpretation of the predictors of ocular ischemic syndrome to improve diagnostic performance HUANG Yingxiang, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China Abstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 1-4.
[2] Carotid artery stenosis is a common clinical disorder. Its main clinical symptoms are transient ischemic attacks and cerebral infarction; ocular ischemic syndrome(OIS)is rare. Its diagnostic imaging modalities include doppler ultrasound imaging, CTA, and MRA. Medical therapy, including risk factor management of atherosclerosis, is necessary for all patients with carotid artery stenosis. Carotid revascularization techniques, including carotid endarterectomy or carotid artery stenting, should be performed for asymptomatic patients with severe carotid artery stenosis and symptomatic patients with moderate carotid stenosis. Patients with carotid artery stenosis need early interventions to prevent stroke, improve ocular artery perfusion, and, ultimately, prevent further vision loss.. Advances in the diagnosis and treatment of carotid artery stenosisXU Zeqin Overview GUO Lianrui Guidance Department of Vascular Surgery, Xuan Wu Hospital and Institute of Vascular Surgery, Capital Medical University, Beijing 100053, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 11-15.
[3] Ocular ischemic syndrome(OIS)is usually undiagnosed or misdiagnosed due to its asymptomatic onset, complicated ocular manifestations, and the lack of awareness, and patients with OIS have a higher mortality. Improving the understanding, diagnosis, and treatment of OIS through multidisciplinary collaboration is key to investigating and preventing systemic vascular events as well as decreasing blindness and mortality. This review summarizes the recent advances in the epidemiology, clinical diagnosis, and management of OIS.. Recent ocular ischemic syndrome advancesWANG Luping Overview HUANG Yingxiang, WANG Yanling Guidance Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 23-27.
[4] ObjectiveObjectiveTo analyze the literature on ocular ischemic syndrome published between January 1, 2014 and December 31, 2019. MethodPapers on OIS that were published between January 1, 2014 and December 31, 2019, were screened and retrieved from the CNKI and WOS databases, and those that were relevant were searched and analyzed. ResultsIn this analysis, 35 Chinese papers on OIS were cited for 41 times with an h-index of 2, while 48 foreign papers were cited for 115 times with an h-index of 6. Of the organizations that published the highest number of papers and had the highest h-indexes, the Capital Medical University and the Polish Medical University of Pomerania were the leading institutions. The Chinese Journal of Ophthalmology was the leading domestic journal, and the Journal of Ophthalmology and Plos One were the leading foreign journals. China published the highest number of papers abroad; China and South Korea had the highest h-indexes. China′s National Natural Science Foundation provided the most support to the field of OIS, accounting for 20.8% of the total domestic literature. The most frequently cited article in the WOS database was by Hayreh, SS, which was on the prevalence and pathogenesis of ocular vascular occlusive disease and melanosis; it was also part of the top ten studies that focused on the utility of OCT in providing insights into OIS and the mechanisms of ischemia and hypoxia. ConclusionThe utility of OCT in providing insights into OIS and the mechanisms of hypoxia and ischemia represents a modern focus of researchers.. Analysis of the literature on ocular ischemic syndrome at home and abroadMENG Bo, HUANG Yingxiang, WANG Kang, ZHAO Lu, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 35-40.
[5] Spectral-domain optical coherence tomography(SD-OCT)was used to measure and observe the characteristics of the subfoveal choroidal thickness(SFCT)in patients with ocular ischemic syndrome(OIS)as well as explore the indicators for early evaluation of OIS. MethodsThis was a retrospective case-control study. Forty-eight patients(48 eyes)were included between January 2017 and January 2020. The patients were divided into two groups: the OIS and the control groups, with each consisting of 24 patients(24 eyes). Their basic information, including age, gender, body mass index(BMI), and the history of diabetes, hypertension, and hyperlipidemia, was collected. SFCT was measured using SD-OCT in EDI mode. The basic data and SFCTs of the two groups were compared. ResultsThere were no significant differences between the ages, gender, BMIs, and the prevalence of diabetes, hypertension, and hyperlipidemia of the two groups(all P>0.05). The mean SFCT of the OIS group was 204.83±27.34 μm, and that of the control group was 226.58±33.49 μm. The differences between the two groups were statistically significant(t=2.464, P=0.018). ConclusionsSFCT was thinner in patients with OIS. SFCT can be used as an indicator for early assessment of OIS.. Analysis of choroidal thickness in patients with ocular ischemic syndromeFU Qiang, WANG Hongxing Department of Ophthalmology, Beijing Chuiyangliu Hospital, Beijing 100022, ChinaAbstract: Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 60-63.
[6] YANG Xiufen, LI Hongyang, ZHAO Lu,WEI Ying, HU Xiangdong, CHEN Jun, WANG Yanling. Clinical and imaging characteristics in patients with ocular ischemic syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 119-123.
[7] CHAI Xuerong, ZHANG Shixi, TAO Yu, SHEN Jiaquan. Effect of intravitreal ranibizumab injection combined with trabelectomy and panretinal photocoagulation for neovascular glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 72-75.
[8] ZHANG Yi-xia, YANG Wei, QIU Ming-lei, CHEN Ning-ning. Earlier panretinal photocoagulation for heavy typeⅡoptic disc vasculitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(4): 66-68.
[9] NIE Qiao-li1,2,TAO Yuan2,WU Xin-yi1, GUO Bai-ling 2. Comparison between combined therapy of trabeculectomy with cyclocryotherapy and single therapy of cyclocryotherapy for neovascular glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(4): 58-61.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!